{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:39:17Z","timestamp":1792201157290,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) has been confirmed to play oncogenic role in many cancers. However, the role and mechanism of IGF2BP2 in bladder cancer (BCa) still deserves to be further revealed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The mRNA and protein levels of IGF2BP2 and neuronilin-1 (NRP1) were detected by real-time quantitative PCR (RT-qPCR) and western blot. Cell proliferation, apoptosis, migration and invasion were determined using colony formation assay, EdU assay, CCK8 assay, flow cytometry and transwell assay. Xenograft tumor model was conducted to evaluate the role of IGF2BP2 in vivo. THP-1-M0 macrophages were co-cultured with the condition medium (CM) of BCa cells to induce polarization. M2 macrophage polarization was assessed by detecting the mRNA levels of M2 macrophage markers using RT-qPCR and measuring the proportion of M2 macrophage markers using flow cytometry. Moreover, MeRIP and RIP assay were performed to assess m6A level and the interaction between IGF2BP2 and NRP1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>IGF2BP2 and NRP1 were upregulated in BCa tissues and cells. IGF2BP2 knockdown suppressed BCa cell growth and metastasis, as well as inhibited BCa tumor growth. After THP-1-M0 macrophages were co-cultured with the CM of BCa cells, the levels of M2 macrophage markers were markedly enhanced, while this effect was abolished by IGF2BP2 knockdown. IGF2BP2 level was positively correlated with NRP1 level, and it could increase NRP1 mRNA stability. NRP1 overexpression reversed the suppressive effect of IGF2BP2 knockdown on M2 macrophage polarization and BCa cell progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>m6A-reader IGF2BP2 enhanced M2 macrophage polarization and BCa cell progression by promoting NRP1 mRNA stability.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12894-024-01534-4","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T08:01:44Z","timestamp":1721116904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["m6A reader IGF2BP2 promotes M2 macrophage polarization and malignant biological behavior of bladder cancer by stabilizing NRP1 mRNA expression"],"prefix":"10.1186","volume":"24","author":[{"given":"Dian","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuquan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenquan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"1534_CR1","doi-asserted-by":"crossref","unstructured":"Dobruch J, Oszczudlowski M. Bladder Cancer: current challenges and future directions. Medicina 2021, 57(8).","DOI":"10.3390\/medicina57080749"},{"issue":"6","key":"1534_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, Gupta S, Smith AB, Williams SB, Lotan Y. Epidemiology, screening, and Prevention of bladder Cancer. Eur Urol Oncol. 2022;5(6):628\u201339.","journal-title":"Eur Urol Oncol"},{"issue":"11","key":"1534_CR3","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1007\/s00345-021-03721-6","volume":"39","author":"J Shou","year":"2021","unstructured":"Shou J, Zhang Q, Zhang D. The prognostic effect of metastasis patterns on overall survival in patients with distant metastatic bladder cancer: a SEER population-based analysis. World J Urol. 2021;39(11):4151\u20138.","journal-title":"World J Urol"},{"issue":"5","key":"1534_CR4","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.euf.2021.11.004","volume":"8","author":"V Fonteyne","year":"2022","unstructured":"Fonteyne V, Dirix P, Van Praet C, Berghen C, Albersen M, Junius S, Liefhooghe N, Noe L, De Meerleer G, Ost P, et al. Adjuvant Radiotherapy after Radical Cystectomy for patients with high-risk muscle-invasive bladder Cancer: results of a Multicentric phase II trial. Eur Urol Focus. 2022;8(5):1238\u201345.","journal-title":"Eur Urol Focus"},{"key":"1534_CR5","doi-asserted-by":"publisher","first-page":"1161273","DOI":"10.3389\/fimmu.2023.1161273","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Li M, Wu W, Miao W, Liu H. Downregulated ESRP1\/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization. Front Immunol. 2023;14:1161273.","journal-title":"Front Immunol"},{"issue":"1","key":"1534_CR6","doi-asserted-by":"publisher","first-page":"9657","DOI":"10.1038\/s41598-023-33915-4","volume":"13","author":"S Liu","year":"2023","unstructured":"Liu S, Liu Z, Shang A, Xun J, Lv Z, Zhou S, Liu C, Zhang Q, Yang Y. CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis. Sci Rep. 2023;13(1):9657.","journal-title":"Sci Rep"},{"key":"1534_CR7","doi-asserted-by":"crossref","unstructured":"Zhang W, Yang F, Zheng Z, Li C, Mao S, Wu Y, Wang R, Zhang J, Zhang Y, Wang H et al. Sulfatase 2 affects polarization of M2 macrophages through the IL-8\/JAK2\/STAT3 pathway in bladder Cancer. Cancers 2022, 15(1).","DOI":"10.3390\/cancers15010131"},{"issue":"1","key":"1534_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12935-021-01799-x","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J, Chen L, Qiang P. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers. Cancer Cell Int. 2021;21(1):99.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1534_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/jcp.30919","volume":"238","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Chen S, Wu T, Chen Y, Cao Y, Huang Y, Liu D. IGF2BP2, an RNA-binding protein regulates cell proliferation and osteogenic differentiation by stabilizing SRF mRNA. J Cell Physiol. 2023;238(1):195\u2013209.","journal-title":"J Cell Physiol"},{"issue":"6","key":"1534_CR10","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1002\/ctm2.426","volume":"11","author":"C Lang","year":"2021","unstructured":"Lang C, Yin C, Lin K, Li Y, Yang Q, Wu Z, Du H, Ren D, Dai Y, Peng X. M(6) a modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Translational Med. 2021;11(6):e426.","journal-title":"Clin Translational Med"},{"issue":"6","key":"1534_CR11","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/s41418-019-0461-z","volume":"27","author":"X Hu","year":"2020","unstructured":"Hu X, Peng WX, Zhou H, Jiang J, Zhou X, Huang D, Mo YY, Yang L. IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader. Cell Death Differ. 2020;27(6):1782\u201394.","journal-title":"Cell Death Differ"},{"issue":"10","key":"1534_CR12","doi-asserted-by":"publisher","first-page":"e23183","DOI":"10.1096\/fj.202202145RRR","volume":"37","author":"Y Shi","year":"2023","unstructured":"Shi Y, Xiong X, Sun Y, Geng Z, Chen X, Cui X, Lv J, Ge L, Jia X, Xu J. IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m(6) A-dependent manner. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2023;37(10):e23183.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"1534_CR13","doi-asserted-by":"crossref","unstructured":"Ouyang J, Li J, Li D, Jiang J, Hao T, Xia Y, Lu X, Zhang C, He Y. IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer. Cancers 2022, 14(21).","DOI":"10.3390\/cancers14215381"},{"key":"1534_CR14","doi-asserted-by":"publisher","first-page":"574196","DOI":"10.3389\/fgene.2021.574196","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Liu Z, Wei X, Feng H, Hu B, Liu B, Luan Y, Ruan Y, Liu X, Liu Z, et al. Identification of the functions and prognostic values of RNA binding proteins in bladder Cancer. Front Genet. 2021;12:574196.","journal-title":"Front Genet"},{"key":"1534_CR15","doi-asserted-by":"publisher","first-page":"110839","DOI":"10.1016\/j.cellsig.2023.110839","volume":"111","author":"X Zhao","year":"2023","unstructured":"Zhao X, Chen J, Zhang C, Xie G, Othmane B, Kuang X, Liu B. LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability. Cell Signal. 2023;111:110839.","journal-title":"Cell Signal"},{"key":"1534_CR16","doi-asserted-by":"crossref","unstructured":"Zhang Y, Guo J, Zhang L, Li Y, Sheng K, Zhang Y, Liu L, Gong W, Guo K. CircASPH enhances exosomal STING to facilitate M2 macrophage polarization in Colorectal Cancer. Inflammatory bowel diseases; 2023.","DOI":"10.1093\/ibd\/izad113"},{"key":"1534_CR17","doi-asserted-by":"crossref","unstructured":"Li H, Luo F, Jiang X, Zhang W, Xiang T, Pan Q, Cai L, Zhao J, Weng D, Li Y et al. CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype. J Immunother Cancer 2022, 10(3).","DOI":"10.1136\/jitc-2021-004029"},{"issue":"43","key":"1534_CR18","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1021\/bi401034q","volume":"52","author":"HF Guo","year":"2013","unstructured":"Guo HF, Li X, Parker MW, Waltenberger J, Becker PM, Vander Kooi CW. Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F. Biochemistry. 2013;52(43):7551\u20138.","journal-title":"Biochemistry"},{"issue":"11","key":"1534_CR19","doi-asserted-by":"publisher","first-page":"e49177","DOI":"10.1371\/journal.pone.0049177","volume":"7","author":"MW Parker","year":"2012","unstructured":"Parker MW, Xu P, Guo HF, Vander Kooi CW. Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition. PLoS ONE. 2012;7(11):e49177.","journal-title":"PLoS ONE"},{"issue":"4","key":"1534_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41419-020-2428-x","volume":"11","author":"B Mei","year":"2020","unstructured":"Mei B, Chen J, Yang N, Peng Y. The regulatory mechanism and biological significance of the Snail-miR590-VEGFR-NRP1 axis in the angiogenesis, growth and metastasis of gastric cancer. Cell Death Dis. 2020;11(4):241.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1534_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41419-023-05696-1","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P, Chen L, Zhou F, He Z, Wang G, Luo Y. NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation. Cell Death Dis. 2023;14(2):159.","journal-title":"Cell Death Dis"},{"key":"1534_CR22","doi-asserted-by":"publisher","first-page":"147413","DOI":"10.1016\/j.gene.2023.147413","volume":"870","author":"Y Tang","year":"2023","unstructured":"Tang Y, Hu S, Li T, Qiu X. Tumor cells-derived exosomal circVCP promoted the progression of colorectal cancer by regulating macrophage M1\/M2 polarization. Gene. 2023;870:147413.","journal-title":"Gene"},{"issue":"9","key":"1534_CR23","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00262-022-03153-0","volume":"71","author":"Y Yu","year":"2022","unstructured":"Yu Y, Zeng H, Jin K, You R, Liu Z, Zhang H, Liu C, Su X, Yan S, Chang Y, et al. Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer. Cancer Immunol Immunotherapy: CII. 2022;71(9):2117\u201326.","journal-title":"Cancer Immunol Immunotherapy: CII"},{"key":"1534_CR24","doi-asserted-by":"crossref","unstructured":"Dong Y, Hao L, Shi ZD, Fang K, Yu H, Zang GH, Fan T, Han CH. Solasonine Induces Apoptosis and Inhibits Proliferation of Bladder Cancer Cells by Suppressing NRP1 Expression. Journal of oncology 2022, 2022:7261486.","DOI":"10.1155\/2022\/7261486"},{"issue":"10","key":"1534_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/iju.13376","volume":"24","author":"J Miyazaki","year":"2017","unstructured":"Miyazaki J, Nishiyama H. Epidemiology of urothelial carcinoma. Int J Urology: Official J Japanese Urol Association. 2017;24(10):730\u20134.","journal-title":"Int J Urology: Official J Japanese Urol Association"},{"issue":"9","key":"1534_CR26","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u201340.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1534_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12967-022-03813-w","volume":"20","author":"M Liu","year":"2022","unstructured":"Liu M, Liu L, Song Y, Li W, Xu L. Targeting macrophages: a novel treatment strategy in solid tumors. J Translational Med. 2022;20(1):586.","journal-title":"J Translational Med"},{"key":"1534_CR28","doi-asserted-by":"crossref","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization States in the Tumor Microenvironment. Int J Mol Sci 2021, 22(13).","DOI":"10.3390\/ijms22136995"},{"issue":"1","key":"1534_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13045-017-0421-3","volume":"10","author":"YJ Huang","year":"2017","unstructured":"Huang YJ, Yang CK, Wei PL, Huynh TT, Whang-Peng J, Meng TC, Hsiao M, Tzeng YM, Wu AT, Yen Y. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways. J Hematol Oncol. 2017;10(1):60.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1534_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","volume":"22","author":"H Zhuang","year":"2023","unstructured":"Zhuang H, Yu B, Tao D, Xu X, Xu Y, Wang J, Jiao Y, Wang L. The role of m6A methylation in therapy resistance in cancer. Mol Cancer. 2023;22(1):91.","journal-title":"Mol Cancer"},{"issue":"10","key":"1534_CR31","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1111\/cas.15083","volume":"112","author":"J Cui","year":"2021","unstructured":"Cui J, Tian J, Wang W, He T, Li X, Gu C, Wang L, Wu J, Shang A. IGF2BP2 promotes the progression of colorectal cancer through a YAP-dependent mechanism. Cancer Sci. 2021;112(10):4087\u201399.","journal-title":"Cancer Sci"},{"issue":"1","key":"1534_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-022-01608-7","volume":"21","author":"B Yao","year":"2022","unstructured":"Yao B, Zhang Q, Yang Z, An F, Nie H, Wang H, Yang C, Sun J, Chen K, Zhou J, et al. CircEZH2\/miR-133b\/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA. Mol Cancer. 2022;21(1):140.","journal-title":"Mol Cancer"},{"key":"1534_CR33","doi-asserted-by":"publisher","first-page":"578816","DOI":"10.3389\/fonc.2020.578816","volume":"10","author":"J Pu","year":"2020","unstructured":"Pu J, Wang J, Qin Z, Wang A, Zhang Y, Wu X, Wu Y, Li W, Xu Z, Lu Y, et al. IGF2BP2 promotes Liver Cancer Growth through an m6A-FEN1-Dependent mechanism. Front Oncol. 2020;10:578816.","journal-title":"Front Oncol"},{"issue":"2","key":"1534_CR34","doi-asserted-by":"publisher","first-page":"113024","DOI":"10.1016\/j.yexcr.2022.113024","volume":"413","author":"L Zhu","year":"2022","unstructured":"Zhu L, Liu Y, Tang H, Wang P. FOXP3 activated-LINC01232 accelerates the stemness of non-small cell lung carcinoma by activating TGF-beta signaling pathway and recruiting IGF2BP2 to stabilize TGFBR1. Exp Cell Res. 2022;413(2):113024.","journal-title":"Exp Cell Res"},{"key":"1534_CR35","doi-asserted-by":"crossref","unstructured":"Ding AX, Wang H, Zhang JM, Yang W, Kuang YT. lncRNA BANCR promotes the colorectal cancer metastasis through accelerating exosomes-mediated M2 macrophage polarization via regulating RhoA\/ROCK signaling. Molecular and cellular biochemistry 2023.","DOI":"10.1007\/s11010-023-04709-z"},{"issue":"1","key":"1534_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-023-01791-1","volume":"22","author":"H Fang","year":"2023","unstructured":"Fang H, Sun Q, Zhou J, Zhang H, Song Q, Zhang H, Yu G, Guo Y, Huang C, Mou Y, et al. M(6)a methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. Mol Cancer. 2023;22(1):99.","journal-title":"Mol Cancer"},{"issue":"4","key":"1534_CR37","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1002\/cam4.5096","volume":"12","author":"P Cao","year":"2023","unstructured":"Cao P, Wu Y, Sun D, Zhang W, Qiu J, Tang Z, Xue X, Qin L. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation. Cancer Med. 2023;12(4):4405\u201320.","journal-title":"Cancer Med"},{"key":"1534_CR38","doi-asserted-by":"crossref","unstructured":"Chuckran CA, Liu C, Bruno TC, Workman CJ, Vignali DA. Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy. J Immunother Cancer 2020, 8(2).","DOI":"10.1136\/jitc-2020-000967"},{"key":"1534_CR39","doi-asserted-by":"publisher","first-page":"823377","DOI":"10.3389\/fonc.2022.823377","volume":"12","author":"P Gao","year":"2022","unstructured":"Gao P, Ren G, Liang J, Liu J. STAT6 upregulates NRP1 expression in endothelial cells and promotes angiogenesis. Front Oncol. 2022;12:823377.","journal-title":"Front Oncol"},{"issue":"4","key":"1534_CR40","doi-asserted-by":"publisher","first-page":"e94422","DOI":"10.1371\/journal.pone.0094422","volume":"9","author":"Y Peng","year":"2014","unstructured":"Peng Y, Liu YM, Li LC, Wang LL, Wu XL. MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PLoS ONE. 2014;9(4):e94422.","journal-title":"PLoS ONE"},{"issue":"16","key":"1534_CR41","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1158\/1078-0432.CCR-07-0001","volume":"13","author":"TM Hong","year":"2007","unstructured":"Hong TM, Chen YL, Wu YY, Yuan A, Chao YC, Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, et al. Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin cancer Research: Official J Am Association Cancer Res. 2007;13(16):4759\u201368.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"key":"1534_CR42","doi-asserted-by":"publisher","first-page":"685980","DOI":"10.3389\/fonc.2021.685980","volume":"11","author":"Y Dong","year":"2021","unstructured":"Dong Y, Ma WM, Shi ZD, Zhang ZG, Zhou JH, Li Y, Zhang SQ, Pang K, Li BB, Zhang WD, et al. Role of NRP1 in bladder Cancer pathogenesis and progression. Front Oncol. 2021;11:685980.","journal-title":"Front Oncol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01534-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-024-01534-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01534-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T08:02:40Z","timestamp":1721116960000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-024-01534-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1534"],"URL":"https:\/\/doi.org\/10.1186\/s12894-024-01534-4","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Jinling College of Clinical Medicine, Nanjing Medical University. Besides, animal experiments were approved by the Animal Ethics Committee of Jinling College of Clinical Medicine, Nanjing Medical University. All experiments were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}